We conducted a single‐centre, retrospective study of adult patients with moderate‐to‐severe plaque psoriasis that discontinued an IL‐17 inhibitor and were subsequently switched to another agent within the same class. The gene discussed is IL17A; the disease is psoriasis vulgaris.